Coronavirus Update: India Approves Remdesivir, Ex-Biogen Employee Charged

Plus: China Secures Vaccines Manufacturing

A former employee of Biogen is officially charged in China for allegedly jeopardizing public health, Wuhan tests 10 million residents, India approves remdesivir.

India_Queue
Guwahati, Assam, India. 2 June. A queue of job applicants at Mahendra Mohan Choudhury Hospital. The country's lockdown has plunged 120m workers into unemployment.

Gilead Sciences Inc. has received the go-ahead in India for Veklury (remdesivir), the antiviral in the forefront as a potential COVID-19 treatment.

The Drugs Controller General of India (DCGI) approved the drug for the treatment of suspected or laboratory confirmed coronavirus disease...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip